![](/img/cover-not-exists.png)
One-year follow-up of mortality in the GUSTO IV trial evaluating the effects of 24 – 48 hours abciximab infusion in noninvasively managed acute coronary syndrome patients
Maarten Simoons, Paul Armstrong, Elliot Barnathane, Robert Califf, Stefan James, Eric Topol, Lars WallentinVolume:
39
Year:
2002
Language:
english
DOI:
10.1016/s0735-1097(02)81337-7
File:
PDF, 159 KB
english, 2002